Abstract:Objective: Several studies have investigated the correlation between blood lipids and homocysteine, but no clear conclusions have been defined yet. Therefore, we utilized data from National Health and Nutrition Examination Survey (NHANES) to explore the correlation between serum homocysteine (Hcy) levels and hyperlipidemia, which is determined by the levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG). We believe this study can provide a scientific basis for the prevention and treatment of lipid abnormalities. Methods: The data used in this study were sourced from NHANES 1999–2006, linked with National Death Index mortality data from January 1999 to December 2019. We employed logistic regression to assess the associations between Hcy levels and the presence of hyperlipidemia. Additionally, survival analysis using Kaplan-Meier estimate and Cox proportional hazards regression model was conducted to evaluate the associations between Hcy levels and all-cause mortality in the hyperlipidemia population. Results: (1) A total of 13,661 subjects were included in the study. There were statistically significant differences in Hcy levels across different groups based on gender, age, race, marital status, education level, hypertension status, diabetes status, and Body Mass Index (BMI) ( P < 0.05). (2) In the overall population, hyperhomocysteinemia (HHcy) was associated with an increased risk of high-TC hyperlipidemia ( P < 0.05). Subgroup analysis by gender showed that HHcy in females was associated with an increased risk of dyslipidemia (OR = 1.30, 95% CI: 1.07–1.59, P < 0.05) and high-LDL-C hyperlipidemia (OR = 1.30, 95% CI: 1.00–1.68, P < 0.05). In addition, subgroup analysis by age revealed that HHcy in middle-aged people was associated with an increased risk of high-TC hyperlipidemia (OR = 1.21, 95% CI: 1.03–1.41, P < 0.05) and high-LDL-C hyperlipidemia (OR = 1.23, 95% CI: 1.06–1.43, P < 0.05). (3) HHcy was consistently associated with an increased mortality risk in the hyperlipidemia population (HR = 1.49, 95% CI: 1.35–1.65, P < 0.05). Conclusion: There was positive correlation between Hcy levels and the presence of hyperlipidemia. In the overall population, HHcy was associated with an increased risk of high-TC hyperlipidemia. Among females, HHcy is linked to an increased risk of dyslipidemia and high-LDL-C hyperlipidemia. In middle-aged people, HHcy was associated with an elevated risk of high-TC hyperlipidemia and high-LDL-C hyperlipidemia. In addition, HHcy increased the all-cause mortality rate in hyperlipidemia patients.

Associations of total homocysteine and kidney function with all-cause and cause-specific mortality in hypertensive patients: a mediation and joint analysis

Homocysteine and All-Cause Mortality in Hypertensive Adults Without Pre-Existing Cardiovascular Conditions: Effect Modification by MTHFR C677T Polymorphism.

Association between hyperhomocysteinaemia and the risk of all-cause and cause-specific mortality among adults in the USA

The Association Between Total Homocysteine and Blood Pressure in Two Independent Chinese Populations.

Hyperhomocysteinemia Predicts Renal Function Decline: a Prospective Study in Hypertensive Adults

The Association of Plasma Homocysteine Concentrations with a 10-Year Risk of All-Cause and Cardiovascular Mortality in a Community-Based Chinese Population

Serum and Tissue Levels of Advanced Glycation End Products and Risk of Mortality in Patients on Maintenance Hemodialysis

Impact of Folic-Acid Intervention and Mthfrc677t Gene Polymorphism on All-Cause Mortality Associated with Elevated Serum Homocysteine Levels in Chinese Adults with Hypertension

Saturation Effects of Plasma Homocysteine on Chronic Kidney Disease in Chinese Adults With H-type Hypertension: A Cross-sectional Study

Homocysteine Metabolism, Subclinical Myocardial Injury, and Cardiovascular Mortality in the General Population

Associations of Meat Consumption and Changes with All-Cause Mortality in Hypertensive Patients During 11.4-Year Follow-Up: Findings from a Population-Based Nationwide Cohort.

Decreased Glomerular Filtration Rate is Associated with Mortality and Cardiovascular Events in Patients with Hypertension: A Prospective Study

H-type Hypertension and Risk of Stroke in Chinese Adults: A Prospective, Nested Case–control Study

Individual and Joint Effects of Borderline Ankle-Brachial Index and High Plasma Total Homocysteine on All-Cause Death in Hypertensive Adults

Threshold effect of plasma total homocysteine levels on cognitive function among hypertensive patients in China: A cross-sectional study

Association between hyperuricemia and long-term mortality in patients with hypertension: results from the NHANES 2001–2018

Associations of uric acid with the risk of cardiovascular disease and all-cause mortality among individuals with chronic kidney disease: the Kailuan Study

Association between homocysteine and incidence of ischemic stroke in subjects with essential hypertension: a matched case-control study.

Influence of renal function on the ability of TyG Index to predict all-cause mortality

Association between homocysteine levels and hyperlipidemia prevalence as well as all-cause mortality of hyperlipidemia patients in the US population: results from NHANES database

Association between the triglyceride to high-density lipoprotein cholesterol ratio and mortality in Chinese maintenance haemodialysis patients: a retrospective cohort study